Cipla Q4 Review - Misses Estimates; Focus Remains Intact: ICICI Direct

Namesign of Cipla on stone plaque outside the company's office. (Source: BloombergQuint).

Cipla Q4 Review - Misses Estimates; Focus Remains Intact: ICICI Direct


BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Cipla Ltd.'s Q4 revenue grew 5.3% YoY to Rs 4,606 crore.

Domestic sales grew 4.5% YoY to Rs 1,807 crore. U.S. grew 17.1% YoY to Rs 1,002 crore on the back of continued Albuterol ramp-up.

Rest of world markets business fell 4.8% YoY to Rs 674 crore.

South Africa business grew 13.9% YoY to Rs 606 crore tracking strong private business momentum.

Ebitda margin expanded 281 basis points YoY (down 653 basis points QoQ) to 17.3% mainly due to significantly lower other expenditure partially offset by lower gross margins.

Subsequently, Ebitda grew 25.7% YoY to Rs 796 crore.

Profit after tax was up 68% YoY to Rs 413 crore.

Click on the attachment to read the full report:

ICICI Direct Cipla Q4FY21 Result Update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.